Abstract
The updated Vitek Yeast Biochemical Card (YBC) was compared with the API 20C by using 409 germ tube-negative yeasts and Geotrichum spp. that were either clinical or proficiency sample isolates. The API 20C was the reference standard. The 409 isolates represented nine genera and 21 species. Morphology agars were inoculated and interpreted for each isolate. The API 20C identified 406 isolates (99.3%), while the Vitek YBC identified 367 (89.7%). Both systems identified the majority of yeasts after 24 h of incubation--73.4% were identified by the API 20C and 77.4% were identified by the Vitek YBC. The Vitek 24-h reading had some incorrect identifications. These included 14 isolates of Candida tropicalis that were identified as Candida parapsilosis (91 to 97% reliability) and 3 isolates of Candida krusei that were called Blastoschizomyces capitatus (Geotrichum capitatum), Candida rugosa, and Candida zeylanoides. In total, the Vitek YBC misidentified 30 isolates, while the API 20C misidentified 3 isolates. In addition, results for 14 isolates with the Vitek YBC were listed under the category "no identification." Morphology agars were required for identification with 89 isolates (21.9%) when the API 20C was used and with 50 isolates (12.6%) when the Vitek YBC was used. Apart from the price of the Vitek instrument, the API 20C costs $1.28 more per test than the Vitek YBC. Overall, the updated Vitek YBC compares favorably with the API 20C in the identification of common yeasts such as Torulopsis glabrata, C. parapsilosis, and Cryptococcus neoformans. However, problems were encountered with the Vitek system in the identification of C. tropicalis, C. krusei, Trichosporon spp., and some Cryptococcus spp. The routine use of morphology agars with either method is recommended.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anaissie E., Bodey G. P. Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am. 1989 Dec;3(4):867–882. [PubMed] [Google Scholar]
- Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S43–S53. doi: 10.1093/clinids/14.supplement_1.s43. [DOI] [PubMed] [Google Scholar]
- Banerjee S. N., Emori T. G., Culver D. H., Gaynes R. P., Jarvis W. R., Horan T., Edwards J. R., Tolson J., Henderson T., Martone W. J. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):86S–89S. doi: 10.1016/0002-9343(91)90349-3. [DOI] [PubMed] [Google Scholar]
- Buesching W. J., Kurek K., Roberts G. D. Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol. 1979 May;9(5):565–569. doi: 10.1128/jcm.9.5.565-569.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fraser V. J., Jones M., Dunkel J., Storfer S., Medoff G., Dunagan W. C. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992 Sep;15(3):414–421. doi: 10.1093/clind/15.3.414. [DOI] [PubMed] [Google Scholar]
- Hasyn J. J., Buckley H. R. Evaluation of the AutoMicrobic system for identification of yeasts. J Clin Microbiol. 1982 Nov;16(5):901–904. doi: 10.1128/jcm.16.5.901-904.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Land G. A., Harrison B. A., Hulme K. L., Cooper B. H., Byrd J. C. Evaluation of the new API 20C strip for yeast identification against a conventional method. J Clin Microbiol. 1979 Sep;10(3):357–364. doi: 10.1128/jcm.10.3.357-364.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Land G., Stotler R., Land K., Staneck J. Update and evaluation of the AutoMicrobic yeast identification system. J Clin Microbiol. 1984 Oct;20(4):649–652. doi: 10.1128/jcm.20.4.649-652.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C. C., Fung D. Y. Conventional and rapid methods for yeast identification. Crit Rev Microbiol. 1987;14(4):273–289. doi: 10.3109/10408418709104441. [DOI] [PubMed] [Google Scholar]
- Oblack D. L., Rhodes J. C., Martin W. J. Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol. 1981 Feb;13(2):351–355. doi: 10.1128/jcm.13.2.351-355.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pfaller M. A., Preston T., Bale M., Koontz F. P., Body B. A. Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates. J Clin Microbiol. 1988 Oct;26(10):2054–2058. doi: 10.1128/jcm.26.10.2054-2058.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis. 1991 May-Jun;13(3):487–492. doi: 10.1093/clinids/13.3.487. [DOI] [PubMed] [Google Scholar]
- Stager C. E., Davis J. R. Automated systems for identification of microorganisms. Clin Microbiol Rev. 1992 Jul;5(3):302–327. doi: 10.1128/cmr.5.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stein D. K., Sugar A. M. Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):221S–228S. doi: 10.1016/0732-8893(89)90140-5. [DOI] [PubMed] [Google Scholar]
- el-Zaatari M., Pasarell L., McGinnis M. R., Buckner J., Land G. A., Salkin I. F. Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol. 1990 Sep;28(9):1938–1941. doi: 10.1128/jcm.28.9.1938-1941.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
